FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to an antibody that specifically binds to FZD10 protein. Polynucleotide encoding the specified antibody is also disclosed. A method for diagnosing FZD10-related disease, a method for detecting FZD10 protein, a method for screening a subject, and a method for obtaining an antibody using the specified antibody are disclosed.
EFFECT: invention has the capability of effective treatment of diseases associated with FZD10 protein.
14 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
MONOCLONAL ANTIBODY AGAINST MELK AND ITS USE | 2017 |
|
RU2756982C2 |
AIMED AT UPARAP ANTIBODY-DRUG CONJUGATES | 2017 |
|
RU2740311C2 |
STABLE COMPOSITIONS OF ANTI-TIGIT ANTIBODIES, INDIVIDUALLY AND IN COMBINATION WITH ANTIBODIES AGAINST PROGRAMMED DEATH RECEPTOR 1 (PD-1), AND METHODS OF THEIR USE | 2018 |
|
RU2820576C2 |
ANTIBODIES AND ANALYSIS METHODS FOR FOLIC ACID 1 RECEPTOR DETECTION | 2014 |
|
RU2725825C2 |
FUNCTION PROTEIN AND ITS USE | 2019 |
|
RU2800923C2 |
ANTIBODIES B7-H4 AND METHODS FOR THEIR APPLICATION | 2019 |
|
RU2809243C2 |
ANTIBODIES TO PROTEIN CD38, AND THEIR USE | 2019 |
|
RU2776795C2 |
HUMAN ANTIBODIES BINDING TO ROR2 | 2018 |
|
RU2784586C2 |
COMPOSITIONS AND METHODS FOR MODULATING THE TRANSMISSION OF A LAIR SIGNAL | 2017 |
|
RU2757394C2 |
PROTEINS BINDING NKG2D, CD16 AND TUMOUR-ASSOCIATED ANTIGEN | 2018 |
|
RU2816716C2 |
Authors
Dates
2022-01-31—Published
2017-10-04—Filed